Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.
Lai, C., Gum, R.J., Daly, M., Fry, E.H., Hutchins, C., Abad-Zapatero, C., von Geldern, T.W.(2006) Bioorg Med Chem Lett 16: 1807-1810
- PubMed: 16446092 
- DOI: https://doi.org/10.1016/j.bmcl.2006.01.014
- Primary Citation of Related Structures:  
2FIE, 2FIX - PubMed Abstract: 
A series of novel benzoxazole benzenesulfonamides was synthesized as inhibitors of fructose-1,6-bisphosphatase (FBPase-1). Extensive SAR studies led to a potent inhibitor, 53, with an IC(50) of 0.57microM. Compound 17 exhibited excellent bioavailability and a good pharmacokinetic profile in rats.
Organizational Affiliation: 
Metabolic Disease Research, GPRD, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. Chunqiu.lai@abbott.com